4//SEC Filing
A2A Pharmaceuticals, Inc. 4
Accession 0001859061-23-000006
CIK 0001840439other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 7:13 AM ET
Size
4.9 KB
Accession
0001859061-23-000006
Insider Transaction Report
Form 4
A2A Pharmaceuticals, Inc.
10% Owner
Transactions
- Sale
Common Stock
2023-05-12$33.84/sh−25,000$846,000→ 3,625,000 total
Footnotes (1)
- [F1]A total of 25,000 shares were sold at an average price of 33.84 in multiple transactions in a range of 33.50 to 34.50. Details of the specific transactions are available upon request.
Documents
Issuer
Biomea Fusion, Inc.
CIK 0001840439
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001859061
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 7:13 AM ET
- Size
- 4.9 KB